scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.MICINF.2018.06.004 |
P698 | PubMed publication ID | 29959095 |
P2093 | author name string | Jason A Tetro | |
P2860 | cites work | Social media and outbreaks of emerging infectious diseases: A systematic review of literature. | Q54239896 |
First reported case of multidrug-resistant Candida auris in Canada. | Q55017741 | ||
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe | Q58924160 | ||
Yellow fever in Brazil: Epidemiological aspects and implications for travelers | Q59361001 | ||
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features | Q70393449 | ||
Isolation of E. coli O157:H7 from sporadic cases of hemorrhagic colitis - United States | Q71635703 | ||
Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada | Q72542036 | ||
Global epidemiology of Clostridium difficile infection in 2010 | Q85170692 | ||
Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage | Q21144503 | ||
Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors | Q21562264 | ||
Zika Virus Outbreak on Yap Island, Federated States of Micronesia | Q22250881 | ||
THE HISTORY OF SCARLET FEVER | Q24644285 | ||
Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype | Q24650779 | ||
Epidemiology of Acute Coccidioidomycosis with Erythema Nodosum ("San Joaquin" or "Valley Fever") | Q24683109 | ||
The discovery of the first human retrovirus: HTLV-1 and HTLV-2 | Q24804470 | ||
The global diet: trade and novel infections | Q24810326 | ||
Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas | Q26996748 | ||
SARS-CoV: Lessons for global health | Q27487847 | ||
The Ebola Outbreak: Catalyzing a "Shift" in Global Health Governance? | Q28119668 | ||
Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom | Q28383363 | ||
Using Social Media for Actionable Disease Surveillance and Outbreak Management: A Systematic Literature Review | Q28606868 | ||
Combining Search, Social Media, and Traditional Data Sources to Improve Influenza Surveillance | Q28608315 | ||
Mass Media and the Contagion of Fear: The Case of Ebola in America | Q28648511 | ||
Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species | Q28829671 | ||
Yellow Fever — Once Again on the Radar Screen in the Americas | Q28954646 | ||
After Ebola in West Africa — Unpredictable Risks, Preventable Epidemics | Q29544577 | ||
Adapting global influenza management strategies to address emerging viruses | Q30431093 | ||
Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans | Q33300604 | ||
Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital | Q33401940 | ||
Landscape and environmental influences on Mycobacterium ulcerans distribution among aquatic sites in Ghana | Q33596630 | ||
Exposure Risk for Infection and Lack of Human-to-Human Transmission of Mycobacterium ulcerans Disease, Australia | Q33597151 | ||
Environmental and Behavioral Drivers of Buruli Ulcer Disease in Selected Communities Along the Densu River Basin of Ghana: A Case-Control Study | Q33636819 | ||
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally | Q33704302 | ||
Impact of changing societal trends on the spread of infections in American and Canadian homes | Q33787205 | ||
Seasonal Pattern of Mycobacterium ulcerans, the Causative Agent of Buruli Ulcer, in the Environment in Ghana | Q33871043 | ||
Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations | Q33884883 | ||
Laboratory confirmation of Buruli ulcer disease in Togo, 2007-2010. | Q33980134 | ||
Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases | Q33983161 | ||
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec | Q34099215 | ||
First three reported cases of nosocomial fungemia caused by Candida auris | Q34196357 | ||
Coccidioidomycosis: epidemiology | Q34356760 | ||
The early history of coccidioidomycosis: 1892-1945. | Q34615523 | ||
Hemorrhagic colitis due to Escherichia coli O157:H7. A rare disease? | Q34726358 | ||
Quantifying reporting timeliness to improve outbreak control | Q35037328 | ||
Emerging fungal infections in immunocompromised patients | Q35161571 | ||
Group A streptococcal endometritis: Report of an outbreak and review of the literature | Q35650088 | ||
Serological evidence of increased Coccidioides immitis infections in western Canada in 1996. | Q35650128 | ||
Overview on SARS in Asia and the world | Q35689776 | ||
A Field Study in Benin to Investigate the Role of Mosquitoes and Other Flying Insects in the Ecology of Mycobacterium ulcerans | Q35702681 | ||
Germs, governance, and global public health in the wake of SARS | Q35739416 | ||
Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001 | Q35873145 | ||
Geographic distribution of endemic fungal infections among older persons, United States | Q35877516 | ||
Coccidioidomycosis among workers at an archeological site, northeastern Utah | Q35880153 | ||
Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain | Q35916054 | ||
The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases | Q36247685 | ||
High-Throughput Carbon Substrate Profiling of Mycobacterium ulcerans Suggests Potential Environmental Reservoirs | Q36251192 | ||
Multiple Introductions and Recent Spread of the Emerging Human Pathogen Mycobacterium ulcerans across Africa | Q36264288 | ||
Disease-induced resource constraints can trigger explosive epidemics | Q36280410 | ||
Epidemiological Aspects and World Distribution of HTLV-1 Infection | Q36400825 | ||
Pathways of Mycobacterium ulcerans infection: a review | Q36402680 | ||
Coccidioidomycosis-associated Deaths, United States, 1990-2008. | Q36574353 | ||
New foci of Buruli ulcer, Angola and Democratic Republic of Congo | Q37072254 | ||
Group A Streptococcus invasive infections: a review | Q37630639 | ||
Applying phylogenomics to understand the emergence of Shiga-toxin-producing Escherichia coli O157:H7 strains causing severe human disease in the UK. | Q37658037 | ||
Molecular Characterization of Mycolactone Producing Mycobacteria from Aquatic Environments in Buruli Ulcer Non-Endemic Areas in Côte d'Ivoire | Q37678481 | ||
Invasive fungal infections in Canada from 1992 to 1994. | Q37985925 | ||
Neonatal Candidemia Caused by Candida haemulonii: Case Report and Review of Literature | Q38349743 | ||
Novel surveillance methods for the control of Ebola virus disease | Q38674663 | ||
Chronic cutaneous mycobacterial ulcers due to Mycobacterium ulcerans (Buruli ulcer): the first indigenous case report from Jordan and a literature review | Q38865706 | ||
Study of a mycobacterium causing skin ulceration in Uganda. | Q38898636 | ||
First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia | Q39092138 | ||
Modeling human mobility responses to the large-scale spreading of infectious diseases | Q39120466 | ||
Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012. | Q39829643 | ||
Geographic patterns and environmental factors associated with human yellow fever presence in the Americas. | Q40039962 | ||
Global and national laboratory networks support high quality surveillance for measles and rubella | Q40172514 | ||
Molecular phylogeny and dissemination of human T-cell lymphotropic virus type I viewed within the context of primate evolution and human migration | Q41386845 | ||
Yellow Fever Vaccine Shortages in the United States and Abroad: A Critical Issue | Q41928257 | ||
Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast | Q41987164 | ||
Buruli ulcer, Nigeria | Q42546903 | ||
Candida auris-associated candidemia, South Africa | Q42712931 | ||
Candida auris candidemia in Kuwait, 2014. | Q42787996 | ||
Epidemic of group A Streptococcus M/emm59 causing invasive disease in Canada | Q42843125 | ||
Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia | Q43168426 | ||
Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features | Q43521723 | ||
Epidemic and economic impacts of delayed detection of foot-and-mouth disease: a case study of a simulated outbreak in California | Q43760088 | ||
Effective population sizes of a major vector of human diseases, Aedes aegypti. | Q44170044 | ||
A localized outbreak of coccidioidomycosis in southern Texas | Q44717060 | ||
Analysis of the infection system of human T-cell leukaemia virus type I based on a mathematical epidemic model | Q45734163 | ||
Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans | Q46241939 | ||
The first detected airline introductions of yellow fever mosquitoes (Aedes aegypti) to Europe, at Schiphol International airport, the Netherlands | Q46245065 | ||
Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? | Q46264615 | ||
A review of influenza detection and prediction through social networking sites | Q47550882 | ||
Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region | Q47709186 | ||
Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen | Q48220845 | ||
Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis | Q48506819 | ||
Emergence of Candida auris: An International Call to Arms | Q48721573 | ||
Coccidioidomycosis: Imported and Possible Domestic Cases in China A Case Report and Review, 1958-2017. | Q49565632 | ||
Coccidioidomycosis Outbreaks, United States and Worldwide, 1940-2015. | Q49820127 | ||
[Coccidioidomycosis in Argentina, 1892-2009]. | Q51157267 | ||
Fatal Yellow Fever in Travelers to Brazil, 2018. | Q51783183 | ||
Why is the distribution of HTLV-I carriers geographically biased? An answer through a mathematical epidemic model. | Q51927934 | ||
Population dynamics of HTLV-I infection: a discrete-time mathematical epidemic model approach. | Q52009257 | ||
An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. | Q53622467 | ||
Molecular detection of Mycobacterium ulcerans in the environment and its relationship with Buruli ulcer occurrence in Zio and Yoto districts of maritime region in Togo. | Q54204356 | ||
Prevalent emm Types among Invasive GAS in Europe and North America since Year 2000. | Q54234537 | ||
Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2016-2017. | Q54237023 | ||
P433 | issue | 1 | |
P921 | main subject | emerging pathogen | Q108429945 |
P304 | page(s) | 4-9 | |
P577 | publication date | 2018-06-27 | |
P1433 | published in | Microbes and Infection | Q15760242 |
P1476 | title | From hidden outbreaks to epidemic emergencies: the threat associated with neglecting emerging pathogens | |
P478 | volume | 21 |
Q90186487 | Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritis | cites work | P2860 |
Search more.